
Access Bio, Inc. — Investor Relations & Filings
Access Bio, Inc. is a company dedicated to the prevention and early diagnosis of infectious diseases through the research, development, and manufacturing of in vitro diagnostic solutions. Its portfolio includes rapid diagnostic tests (RDTs), immunochemical diagnostics, biosensors, and molecular diagnostic products. The company is recognized for commercializing high-quality tests to combat significant global health threats, including malaria, COVID-19, HIV, and HPV. With a large-scale manufacturing capacity, Access Bio distributes its products globally, serving as a key partner in global health, particularly in the fight against often-neglected diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 반기보고서 (2025.06) | 2025-08-14 | Korean | |
| 반기또는분기매출액미달사실발생 | 2025-08-14 | Korean | |
| 기타시장안내 (상장적격성 실질심사 관련) | 2025-08-14 | Korean | |
| 주권매매거래정지 (상장적격성 실질심사 대상 (사유발생)) | 2025-08-14 | Korean | |
| [기재정정]주식매수선택권부여에관한신고 | 2025-05-20 | Korean | |
| 분기보고서 (2025.03) | 2025-05-15 | Korean |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 7872478 | 반기보고서 (2025.06) | 2025-08-14 | Korean | ||
| 7871600 | 반기또는분기매출액미달사실발생 | 2025-08-14 | Korean | ||
| 7871599 | 기타시장안내 (상장적격성 실질심사 관련) | 2025-08-14 | Korean | ||
| 7871598 | 주권매매거래정지 (상장적격성 실질심사 대상 (사유발생)) | 2025-08-14 | Korean | ||
| 7899727 | [기재정정]주식매수선택권부여에관한신고 | 2025-05-20 | Korean | ||
| 7900742 | 분기보고서 (2025.03) | 2025-05-15 | Korean | ||
| 7914881 | 주식등의대량보유상황보고서(일반) | 2025-04-07 | Korean | ||
| 7921918 | 정기주주총회결과 | 2025-03-26 | Korean | ||
| 7921909 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2025-03-26 | Korean | ||
| 7952018 | 감사보고서제출 | 2025-03-18 | Korean | ||
| 7952003 | 사업보고서 (2024.12) | 2025-03-18 | Korean | ||
| 7960184 | 주주총회소집결의 | 2025-03-11 | Korean | ||
| 7960158 | 주주총회소집공고 | 2025-03-11 | Korean | ||
| 7960146 | 의결권대리행사권유참고서류 | 2025-03-11 | Korean | ||
| 7962027 | 매출액또는손익구조30%(대규모법인은15%)이상변동 | 2025-03-07 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Access Bio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/16670/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=16670 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=16670 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=16670 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 16670}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Access Bio, Inc. (id: 16670)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.